[1] FENTON A J. Premature ovarian insufficiency: Pathogenesis and management[J]. J Midlife Health, 2015, 6(4): 147-153.
[2] 杨念念, 严亚琼, 龚洁, 等. 中国2003~2007年卵巢癌发病与死亡分析[J]. 中国肿瘤, 2012, 21(6): 401-405.
[3] PÉREZ-ANDÚJAR A, NEWHAUSER W D, TADDEI P J, et al. The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation[J]. Phys Med Biol, 2013, 58(10): 3107-3123.
[4] MAYORGA J, ALPÍZAR-RODRÍGUEZ D, PRIETO-PADILLA J, et al. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus[J]. Lupus, 2016,25(7): 675-683.
[5] MEATTINI I, SAIEVA C, MEACCI F, et al. Impact of ageon cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin[J]. Future Oncol, 2016, 12(5): 625-635.
[6] JORDAN S J, WILSON L F, NAGLE C M, et al. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy[J]. Aust N Z J Public Health, 2015, 39(5): 434-440.
[7] LARONDA M M, JAKUS A E, WHELAN K A, et al. Initiation of puberty in mice following decellularized ovary transplant[J]. Biomaterials, 2015, 50: 20-29.
[8] OTT H C, MATTHIESEN T S, GOH S K, et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart[J]. Nat Med, 2008, 14(2): 213-221.
[9] BADYLAK S F, GILBERT T W. Immune response to biologic scaffold materials[J]. Semin Immunol, 2008, 20(2): 109-116.
[10] 张建色, 王辉, 邵培刚, 等. 去细胞全肾生物支架的制备与鉴定[J]. 解剖学报, 2012, 43(2): 253-257.
[11] MAZZA G, ROMBOUTS K, RENNIE H A, et al. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation[J]. Sci Rep, 2015, 5: 13079.
[12] 陈婵, 王志斌, 翁杰, 等. 全肺去细胞生物支架的制备与鉴定[J]. 温州医科大学学报, 2016, 46(2): 88-91.
[13] 林贤丰, 邵营宽, 王辉, 等. 离体大鼠胰腺去细胞生物支架的制备与鉴定[J]. 解剖学报, 2012, 43(5): 717-722.
[14] 彭蒙蒙, 林贤丰, 邵培刚, 等. 灌注法制备离体大鼠心脏脱细胞基质[J]. 解剖学报, 2012, 43(4): 559-563.
[15] JIANG T, REN X J, TANG J L, et al. Preparation and characterization of genipin-crosslinked rat acellular spinal cord scaffolds[J]. Mater Sci Eng C Mater Biol Appl, 2013, 33(6): 3514-3521.
[16] SOLEIMANI R, HEYTENS E, OKTAY K. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants[J]. PLoS One, 2011, 6(4): e19475.
[17] CRAPO P M, GILBERT T W, BADYLAK S F. An overview of tissue and whole organ decellularization processes[J].Biomaterials, 2011, 32(12): 3233-3243.
[18] WANG X, CUI J, ZHANG B Q, et al. Decellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors[J]. J Biomed Mater Res A, 2014, 102(4): 1017-1025.
[19] LU X, LI W, FUKUMOTO S, et al. The ameloblastin extracellular matrix molecule enhances bone fracture resistance and promotes rapid bone fracture healing[J]. Matrix Biol, 2016, 52-54: 113-126.
[20] LI H, JIANG W, REN W, et al. Downregulation of the Yesassociated protein is associated with extracellular matrix disorders in ascending aortic aneurysms[J]. Stem Cells Int, 2016, 2016: 6786184.
[21] JIANG W C, CHENG Y H, YEN M H, et al. Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering[J]. Biomaterials, 2014, 35(11): 3607-3617.
[22] LECHT S, STABLER C T, RYLANDER A L, et al. Enhanced reseeding of decellularized rodent lungs with mouse embryonic stem cells[J]. Biomaterials, 2014, 35(10): 3252-3262.
[23] YU Y L, SHAO Y K, DING Y Q, et al. Decellularized kidney scaffold-mediated renal regeneration[J]. Biomaterials, 2014, 35(25): 6822-6828.
[24] ZHANG J, WANG Z, LIN K, et al. In vivo regeneration of renal vessels post whole decellularized kidneys transplantation[J]. Oncotarget, 2015, 6(38): 40433-40442.
[25] MEI J, YU Y, LI M, et al. The angiogenesis in decellularized scaffold-mediated the renal regeneration[J]. Oncotarget, 2016, 7(19): 27085-27093.
[26] LÜ X, ZHAI W, ZHOU Y, et al. Crosslinking effect of Nordihydroguaiaretic acid (NDGA) on decellularized heart valve scaffold for tissue engineering[J]. J Mater Sci Mater Med, 2010, 21(2): 473-480.
|